Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
Saved in:
| Title: | Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies. |
|---|---|
| Authors: | Rascol, Olivier1 (AUTHOR), Tönges, Lars1,2,3 (AUTHOR) lars.toenges@ruhr-uni-bochum.de, deVries, Tina4 (AUTHOR), Jaros, Mark4,5 (AUTHOR), Quartel, Adrian6 (AUTHOR), Jacobs, David4 (AUTHOR), ALLAY-LID I and ALLAY-LID II study groups (CORPORATE AUTHOR) |
| Source: | Parkinsonism & Related Disorders. Mar2022, Vol. 96, p65-73. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
